Concerned Doctors

Location

Alabama

Contact

info@concerneddoctors.org
  • Home
  • Breaking
  • Our Board
    • Jordan Vaughn, MD
    • David Calderwood, MD
    • Stewart Tankersley, MD
    • David L. Williams, MD
  • Events
    • Birmingham Covid Truth Full Video
    • Covid Truths September 19, 2:30 – 5pm – Birmingham Marriott
    • Covid Truth Summit The Westin Huntsville, November 14th, 2021
    • COVID Truths Doctors’ Forum-Montgomery Oct 26, 2021
  • Brochure
    • Covid brochure
    • Brochure references
  • Podcast
    • Intro: Peter McCullough interviews Stewart Tankersley, MD. and Jordan Vaughn, MD.
    • Episode 1 – Your Patient’s Health Should Supplant ‘Public’ Health
    • Episode 2 – Reject the Government’s Request to ‘Control Your Freedom’
    • Episode 3 – Informed Consent Has Been Replaced, the Result is Medical Tyranny
    • Episode 4 – Was it a Failed Response or a Forced Crisis?
    • Episode 5 – What is the Composition of ‘THE SCIENCE’ You Speak Of?
    • Episode 6 – Did the Elites Move the Goal Post or Only Recently Post the Real Goals?
    • Episode 7 – W.H.O. is Really in Control of Your Health Decisions?
    • Episode 8 – The Real Emergency is Using Emergency for Political Purposes
  • Press
    • CONCERNED DOCTORS WILLING TO ASSIST ALL CANDIDATES
    • CONCERNED DOCTORS CALL FOR IMMEDIATE END OF COVID-19 VACCINES AND BOOSTERS FOR MINORS
  • Donate
  • Volunteer
  • Subscribe
  • FAQ

Merck’s COVID-19 pill significantly less effective in new analysis

Home » breaking news » Merck’s COVID-19 pill significantly less effective in new analysis

By admin • November 29, 2021 • No Comments

Merck & Co said on Friday updated data from its study of its experimental COVID-19 pill showed the drug was significantly less effective in cutting hospitalizations and deaths than previously reported.

The drugmaker said its pill showed a 30% reduction in hospitalizations and deaths, based on data from 1,433 patients. In October, its data nL1N2QX0QJ showed a roughly 50% efficacy, based on data from 775 patients. The drug, molnupiravir, was developed with partner Ridgeback Biotherapeutics.

The lower efficacy of Merck’s drug could have big implications in terms of whether countries continue to buy the pill. Interim data from 1,200 participants in Pfizer Inc’s trial for its experimental pill, Paxlovid, showed an 89% reduction in hopsitalizations and deaths.

Click here to read the full article

https://news.trust.org/item/20211126165720-2gs9t/?fbclid=IwAR3cTGtuDwXk2WSET2W-rZxsnZRxLbmRqNzKUeW2bAyHFN2px5UjfeZ2-AI

Facebook
Twitter
Categories:breaking news

admin

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Copyright © Foundation for Concerned Doctors and Patients | Design by TallyThemes
  • Q & A
  • FAQ
  • Masks
  • Find a Doc
  • Find Meds
  • Protocols
  • Physicians
  • Exemptions
  • Legal Assistance
  • Share your story
  • Nuremberg Code
  • Rome Declaration
  • Speaker request form
  • Monoclonal Antibodies
  • Safety and Effectiveness
  • Declaration of Helsinki
  • Protocol for Long Haul COVID-19